NURS6630 PSYCHOPATHOLOGY ACTUAL FINAL EXAM
COMPLETE QUESTIONS AND ANSWERS 2024 : WALDEN
UNIVERSITY
QUESTION 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs
to manage the top-down cortical control and the excessive drive from striatal hyperactivity?
A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs
QUESTION 2
The PMHNP is selecting a medication treatment option for a patient who is exhibiting
psychotic behaviors with poor impulse control and aggression. Of the available treatments,
which can help temper some of the adverse effects or symptoms that are normally caused by
D2 antagonism?
A. First-generation, conventional antipsychotics B. First-generation, atypical antipsychotics C.
Second-generation, conventional antipsychotics D. Second-generation, atypical
antipsychotics
QUESTION 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a standard
dose of atypical antipsychotics?
,A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are based on
achieving a minimum of 80% D2 receptor occupancy. C. The doses are based on achieving
60% D2 receptor occupancy. D. None of the above.
QUESTION 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects. B. It can exaggerate the psychotic
symptoms. C. Clozapine (Clozaril) should not be used as high-dose monotherapy. D. There is
no documentation that clozapine (Clozaril) is effective for patients who are violent.
QUESTION 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12
mg/dail
C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a higher
dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy
QUESTION 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer
, will the PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C. Valproate
(Depakote) D. Topiramate (Topamax)
QUESTION 7
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants
on their child. The parents prefer to start pharmacological treatment with a non-stimulant.
Which medication will the PMHNP will most likely prescribe?
A. Strattera B. Concerta C. Daytrana D.
Adderall QUESTION 8
8 The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient
QUESTION 9
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
A. The formulation can have delayed actions when taken with food. B. Sedation can be a
common side effect of the drug. C. The medication can affect your blood pressure. D. This
drug does not cause any dependency.
QUESTION 10
COMPLETE QUESTIONS AND ANSWERS 2024 : WALDEN
UNIVERSITY
QUESTION 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs
to manage the top-down cortical control and the excessive drive from striatal hyperactivity?
A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs
QUESTION 2
The PMHNP is selecting a medication treatment option for a patient who is exhibiting
psychotic behaviors with poor impulse control and aggression. Of the available treatments,
which can help temper some of the adverse effects or symptoms that are normally caused by
D2 antagonism?
A. First-generation, conventional antipsychotics B. First-generation, atypical antipsychotics C.
Second-generation, conventional antipsychotics D. Second-generation, atypical
antipsychotics
QUESTION 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a standard
dose of atypical antipsychotics?
,A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are based on
achieving a minimum of 80% D2 receptor occupancy. C. The doses are based on achieving
60% D2 receptor occupancy. D. None of the above.
QUESTION 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects. B. It can exaggerate the psychotic
symptoms. C. Clozapine (Clozaril) should not be used as high-dose monotherapy. D. There is
no documentation that clozapine (Clozaril) is effective for patients who are violent.
QUESTION 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12
mg/dail
C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a higher
dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy
QUESTION 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer
, will the PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C. Valproate
(Depakote) D. Topiramate (Topamax)
QUESTION 7
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants
on their child. The parents prefer to start pharmacological treatment with a non-stimulant.
Which medication will the PMHNP will most likely prescribe?
A. Strattera B. Concerta C. Daytrana D.
Adderall QUESTION 8
8 The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient
QUESTION 9
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
A. The formulation can have delayed actions when taken with food. B. Sedation can be a
common side effect of the drug. C. The medication can affect your blood pressure. D. This
drug does not cause any dependency.
QUESTION 10
